Bioniche signs agreement for veterinary technology

Guest Contributor
July 6, 2010

Bioniche Life Sciences Inc, Belleville ON, has signed an agreement with Trophogen Inc, Rockville MD, to gain commercial access to its proprietary superagonist hormone technology platform. The technology will be developed into a next generation follicle stimulating hormone that will greatly increase receptor binding activity as well as vitro and in vivo potency. The two firms will also work together to co-develop new veterinary products. Bioniche holds an option to license additional veterinary reproductive products using Trophogen's technology….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.